medigraphic.com
ISSN 0210-5187 (Electronic)

2008, Number 3

<< Back Next >>

Med Cutan Iber Lat Am 2008; 36 (3)

Treatment of multiple filiform facial wart with 5-fluorouracil & topical retinoids. Report case

Tarango-Martínez VM, Valderrama VC, Romo SC

Language: Spanish
References: 20
Page: 137-141
PDF size: 215.99 Kb.


ABSTRACT

The warts are very common in the medical practice, specially filiform warts which are located more frequently in the face. A 51 years old man with numerous filiform warts located in an area of the beard extended to the maxillar region and the neck, of two years of evolution is presented. Previously he had aplied topical steroids. A combined topical treatment with: 5-fluorouracilo 5% + retinoic acid 0.05% rwice a day resolves with the complete disappearance of the lessons in 30 days.


REFERENCES

  1. Rassner G. Manual y Atlas de Dermatología. Ed. Harcourt 5ª edición 1999;63-5.

  2. Contreras F, Robledo MC, Vázquez J. Papilomavirus y manifestaciones cutáneas. Piel 1993;8:24-30.

  3. Ocampo C. Verrugas Virales Diseminadas (Estudio Inmunológico). Dermatología Rev Mex 1988;32:44-5.

  4. Nebesio C, Mirowski G, Chiang T. Human papillomavirus: clinical significance and malignant potential. Int J Dermatol 2001:373-9.

  5. Gutiérrez L, Flores H, León G, Arellano I. Virus y autoinmunidad. Dermatología Rev Mex 1999;43:17-9.

  6. Tyring S. Human papillomavirus infections: Epidemiology, pathogenesis, and host immune response. J Am Acad Dermatol 2000;43:S18-S25.

  7. Sterling J, Handfield S, Hudson P. Guidelines for the management of cutaneous warts. Br J Dermatol 2001;144:4-11.

  8. Berman B, Weinstein A. Treatment of warts. Dermatol Therapy. 2000;13:290-301.

  9. Phelps W, Alexander K. Antiviral Therapy for Human Papillomaviruses: Rationale and Prospects. Ann Intern Med 1995;123:368-82.

  10. Rosado-Cancino M, Ruiz-Maldonado R, Tamayo L, Laterza A. Tratamiento de verrugas vulgares múltiples y recalcitrantes con 1-cloro-2, 4 dinitrobenceno (DNCB) o placebo en pacientes pediátricos. Dermatología Rev Mex 1989;33:245-52.

  11. Alarcón H, Cancela R. Imiquimod 5%: estudio piloto en niños con verrugas virales perianales recalcitrantes. Dermatología Rev Mex 2001;45:222-6.

  12. Skinner RB. Imiquimod. Dermatol Clinics 2003.

  13. Sauder DN. New Immune therapies for skin disease: imiquimod and related compounds. J Cutan Med Surg 2001:1-6.

  14. Schwab R, Elston D. Topical Imiquimod for Recalcitrant Facial Flat Warts. Cutis 2000;65:160-2.

  15. Hagman JH, Bianchi L, Marulli GC, Soda R. Successful treatment of multiple filiform facial wart with imiquimod 5% cream in a patient infected human immunodeficiency virus. Clin Exp Dermatol 2003;28:260-1.

  16. Rolewski S. Clinical Review: Topical Retinoids. Dermatol Nursing 2003;15:447-64.

  17. Aboosi M. Treatment of Plane Warts by Tretinoin-Induced Irritant Reaction. Int J Dermatol 1994;33:826-7.

  18. Halasz CL. Treatment of Warts with Topical Pyruvic Acid: With and Without Added 5-Fluorouracil. Cutis 1998;62:283-5.

  19. Klaus D. Topical chemotherapy with 5-fluorouracil. J Am Acad Dermatol 1981;4:633-49.

  20. Brazzini B, Pimpinelli N. New and Established Topical Corticosteroids in Dermatology. Clinical Pharmacology and Therapeutic Use. Am J Clin Dermatol 2002;3:47-58.




2020     |     www.medigraphic.com